CLU-IN Home

U.S. EPA Contaminated Site Cleanup Information (CLU-IN)


U.S. Environmental Protection Agency
U.S. EPA Technology Innovation and Field Services Division

Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the Hazardous Waste Listing for Nicotine

Sponsored by: U.S. EPA Office of Resource Conservation and Recovery (ORCR)

Go to Archive

In the fall of 2018, EPA finalized tailored and streamlined standards for managing hazardous waste pharmaceuticals that reduce the cost and compliance burden for the healthcare sector, while ensuring the safe management of hazardous waste pharmaceuticals. These changes provide regulatory certainty and national consistency on how the Resource Conservation and Recovery Act (RCRA) applies to the reverse distribution of prescription pharmaceuticals while incorporating flexibilities to accommodate current business practices.

With this rule EPA is also taking a common-sense regulatory approach to the disposal of Food and Drug Administration (FDA)-approved, over-the-counter nicotine replacement therapies (i.e., patches, gums and lozenges), which will no longer be considered hazardous waste when discarded.

Join us for a webinar to learn more about these regulatory changes.

Please see EPA's website for this rule for more information and to access additional resources: https://www.epa.gov/hwgenerators/management-pharmaceutical-hazardous-waste.


Top of Page

If you have a suggested topic or idea for a future CLU-IN internet seminar, please contact:

Jean Balent
Technology Integration and Information Branch

PH: 202-566-0832 | Email: balent.jean@epa.gov
Michael Adam
Technology Integration and Information Branch

PH: 202-566-0875 | Email: adam.michael@epa.gov